国产氨羟丙基双磷酸盐治疗骨转移癌疼痛疗效观察

张永强;程刚;赵云博;伍建宇;周美珍;许佩珉;

中国药学杂志 ›› 2001, Vol. 36 ›› Issue (11) : 773-774.

中国药学杂志 ›› 2001, Vol. 36 ›› Issue (11) : 773-774.
药物与临床

国产氨羟丙基双磷酸盐治疗骨转移癌疼痛疗效观察

  • 张永强;程刚;赵云博;伍建宇;周美珍;许佩珉;
作者信息 +

Evaluating the efficacy of intravenous pamidronate for metastatic bone pain

  • ZHANG Yong-qiang;CHENG Gang;ZHAO Yun-bo;WU Jian-yu;ZHOU Mei-zhen;XU Pei-min;
Author information +
文章历史 +

摘要

目的 观察国产氨羟丙基双磷酸盐(APD)对恶性肿瘤骨转移引起疼痛的治疗效果和活动能力改善情况。方法 30例确诊为恶性肿瘤伴骨转移疼痛患者均静滴APD 90 mg。结果 止痛显效7例,有效17例,总有效率80%。活动能力改善效果:显效6例,有效7例,总有效率59.1%。大部分病例3 d起效,维持28 d。不良反应主要为发热(20%)。结论 国产APD对恶性肿瘤骨转移疼痛和由此引起的活动能力减退有良好的治疗效果。

Abstract

OBJECTIVE To evaluate the efficacy of Pamidronate (APD) to relieve pain due to metastatic bone tumor and improve the activity of daily living (ADL).METHODS 30 patients with painful progressing bone metastatic tumor were administered in a dosage of 90 mg of APD by intravenous infusion.RESULTS The complete relief and partial relief of pain were observed in 7 and 17 patients respectively,the total effective rate was 80%.The complete relief and partial relief of ADL were observed in 6 and 7 patients respectively,the total effective rate was 59.1%.The common side-effect was transient self-limiting pyrexia 20%(6/30).CONCLUSION APD is effective for relieving pain and improving ADL in patients with advanced cancer,and is well tolerated.

关键词

氨羟丙基双磷酸盐 / 骨转移疼痛 / 止痛

Key words

pamidronate / metastatic bone pain / analgesia/therapeutic use

引用本文

导出引用
张永强;程刚;赵云博;伍建宇;周美珍;许佩珉;. 国产氨羟丙基双磷酸盐治疗骨转移癌疼痛疗效观察[J]. 中国药学杂志, 2001, 36(11): 773-774
ZHNG Yong-qing;CHENG Gng;ZHO Yun-o;WU Jin-yu;ZHOU Mei-zhen;XU Pei-min;. Evaluating the efficacy of intravenous pamidronate for metastatic bone pain[J]. Chinese Pharmaceutical Journal, 2001, 36(11): 773-774

参考文献

[1]张天泽,徐光炜主编.现代肿瘤学(下册)[M].天津:天津科学技术出版社,1996,2725~2735. [2]Rosen CJ,Kessenich CR.Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases[J].Drugs,1966,51:537. [3]Body JJ,Bartl R,Burckhardt P,et al.Current use of bisphosphonates in oncology.International Bone and Cancer Study Group[J].J Clin Oncol,1998,16(12):3880. [4]Plosker GL,Goa KL.Clodronate:a review of its pharmacological properties and therapeutic efficacy in resorptive bone disease[J].Drugs,1994,47(6):945. [5]Cascinu S,Casadei V,Del Ferro E,et al.Pamidronate in patients with painful bone metastases,who failed initial treatment with hormones and/or chemotherapy[J].Support Care Cancer,1996,4(1):31. [6]Koeberle D,Bacchus L,Thuerlimann B,et al.Pamidronate treatment in patients with malignant osteolytic bone disease and pain:a prospective randomized double-blind trial[J].Support Care Cancer,1999,7(1):21. [7]Purohit OP,Anthony C,Radstone CR,et al.High-dose intravenous pamidronate for metastatic bone pain[J].Br J Cancer,1994,70(3):554. [8]金懋林,杨伯琴,雷兰英,等.帕米磷酸钠治疗骨转移引起疼痛的疗效观察[J].中华肿瘤杂志,1998,20(4):310. [9]曹军宁,许立功,于雄,等.帕米磷酸二钠Ⅲ期临床试验报告[J].中国癌症杂志,1999,9(1):77.

Accesses

Citation

Detail

段落导航
相关文章

/